Gaithersburg, MD, August 1, 2017 -- Novavax, Inc. (Nasdaq:NVAX) today announced it will report its second quarter financial and operating results following the close of U.S. financial markets on Tuesday, August 8, 2017.
Conference call details are as follows:
Date: Tuesday, August 8, 2017
Time: 4:30 p.m. U.S. Eastern Time (ET)
Dial-in number: (877) 212-6076 (Domestic) or (707) 287-9331 (International)
Webcast: www.novavax.com, “Investors”/ “Events”
Conference call and webcast replay:
Dates: Starts at 7:30 p.m. ET, August 8, 2017 until 7:30 pm ET, August 15, 2017
Dial-in number: (855) 859-2056 (Domestic) or (404) 537-3406 (International)
Webcast: www.novavax.com, “Investors”/ “Events”, until November 8, 2017
Novavax, Inc. (Nasdaq:NVAX) is a clinical-stage biotechnology company committed to delivering novel products to prevent a broad range of infectious diseases. Its recombinant nanoparticles and Matrix-M™ adjuvant technology are the foundation for groundbreaking innovation that improves global health through safe and effective vaccines.
Andrea N. Flynn, Ph.D.
Director, Investor Relations
Russo Partners, LLC
Todd Davenport, Ph.D.